Section Ph 2102.01 - Definitions In addition to the definitions in RSA 318:1, the following definitions shall apply to this chapter:
(a) "Clinics" means an institution, building, or part of a building devoted to the diagnosis and care of outpatient ambulatory patients. The term also includes public health clinics and methadone clinics;(b) "Compounding pharmacy" means a pharmacy licensed to perform the preparation, mixing, assembling, packaging or labeling of a drug or device as a result of a practitioner's prescription drug order;(c) "Facility" means any pharmacy, hospital, medical clinic, practitioner office, methadone clinic, or veterinarian clinic that has prescription drugs on its premises and is inspected by the pharmacy board;(d) "High risk compounding" means compounding that requires the use of non-sterile ingredients or non-sterile devices, which usually creates a high-risk condition. Exposing sterile ingredients and devices to air quality below ISO Class 5, an International Organization for Standardization metric for environmental management, will create a high-risk compounding situation, as will the prolonged storage of opened or partially-used products that lack antimicrobial preservatives in an environment in less than ISO Class 5 conditions;(e) "In-patient institution" means a facility where a patient is formally admitted or hospitalized for treatment or care and stays for a minimum of one night in the hospital or other institution providing in-patient care; (f) "Inspector" means a pharmacist or certified pharmacy technician employed by the pharmacy board to inspect facilities, to ensure that they comply with federal and state law and the rules established by the board; (g) "Institution" means an "institution" as defined in Ph 701.02(h), namely a health care facility which provides inpatient care and includes: (3) Extended care facilities;(4) Residential care facilities;(6) Correctional facilities.(h) "Institutional pharmacy" means an "institutional pharmacy" as defined in Ph 701.02(i), namely "an area in an institution where drugs are stored, manufactured, compounded, dispensed, or issued to other areas or departments of the institution;"(i) "Investigator" means a pharmacist employed by the pharmacy board to investigate consumer complaints of pharmacy law or rule violations by a person licensed at the time the alleged violation occurred;(j) "Licensee" means any person or entity which is licensed, certified, registered, or regulated by the pharmacy board or a board listed in RSA 318:8-a and RSA 318:9-a;(k) "Limited retail drug distributor" means a distributor of prescription devices or medical gases delivered directly to the consumer pursuant to a practitioner's prescription order, or federally funded clinics operated under contract with the department of health and human services and drug abuse treatment centers, where legend and controlled drugs are held, stored, or dispensed to patients pursuant to the order of an authorized practitioner;(l) "Limited retail drug distributor'' means a distributor of legend devices or medical gases delivered directly to the consumer pursuant to a practitioner's prescription order, or federally funded clinics operated under contract with the department of health and human services and drug abuse treatment centers, where legend and controlled drugs are held, stored, or dispensed to patients pursuant to the order of an authorized practitioner;(m) "Methadone clinic" is a clinic which has been established for the dispensing of methadone and other medications to treat opioid addiction. In the United States, by law, patients must receive methadone under the supervision of a physician, and dispensed through an opioid treatment program certified by Substance Abuse and Mental Health Services Administration and registered with the Drug Enforcement Agency;(n) "Practitioner" means any person who is lawfully entitled to prescribe, administer, dispense or distribute prescription drugs to patients;(o) "Public health clinics", are private, nonprofit organizations that directly or indirectly, through contracts and cooperative agreements, provide primary health services and related services to residents of a defined geographic area that is medically underserved. The term includes "community health centers (CHCs); and(p) "Retail pharmacy" means a pharmacy that dispenses and sells prescription drugs to patients with a valid prescription in an outpatient setting at retail prices.N.H. Admin. Code § Ph 2102.01
Derived from Volume XL Number 19, Filed May 7, 2020, Proposed by #13028, Effective 4/11/2020, Expires 4/11/2030.